A share price of Macrogenics Inc [MGNX] is currently trading at $1.83, up 2.23%. An important factor to consider is whether the stock is rising or falling in short-term value. The MGNX shares have gain 13.66% over the last week, with a monthly amount glided 31.65%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, JMP Securities downgraded its rating to Mkt Perform on November 07, 2024. On August 01, 2024, downgrade downgraded it’s rating to Neutral. Guggenheim downgraded its rating to a Neutral. B. Riley Securities downgraded its rating to a Neutral and reduced its price target to $5 on July 31, 2024. TD Cowen downgraded its rating to Hold for this stock on May 10, 2024. In a note dated May 10, 2024, Stifel downgraded an Hold rating on this stock and revised its target price from $29 to $7.
Macrogenics Inc experienced fluctuations in its stock price throughout the past year between $0.99 and $3.37. Currently, Wall Street analysts expect the stock to reach $9.44 within the next 12 months. Macrogenics Inc [NASDAQ: MGNX] shares were valued at $1.83 at the most recent close of the market. An investor can expect a potential return of 415.85% based on the average MGNX price forecast.
Analyzing the MGNX fundamentals
Trailing Twelve Months sales for Macrogenics Inc [NASDAQ:MGNX] were 127.62M which represents -34.21% decline. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at -0.9%, Pretax Profit Margin comes in at -0.59%, and Net Profit Margin reading is -0.6%. To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -0.98 and Total Capital is -0.5. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.55.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Macrogenics Inc [NASDAQ:MGNX] is 5.22. On the other hand, the Quick Ratio is 5.02, and the Cash Ratio is 1.8. Considering the valuation of this stock, the price to sales ratio is 0.89, the price to book ratio is 1.73.
Transactions by insiders
Recent insider trading involved HEIDEN WILLIAM K, Director, that happened on Aug 19 ’25 when 50500.0 shares were purchased. Director, HEIDEN WILLIAM K completed a deal on Aug 20 ’25 to buy 49500.0 shares. Meanwhile, VP, Controller & Treasurer Smith Beth Ann sold 423.0 shares on Feb 15 ’25.
